Complete Story
 

06/18/2022

COVID Vaccine Rollout for U.S. Children Close After CDC Panel Vote

It's likely a nationwide rollout can start next week

A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Saturday voted to recommend COVID-19 vaccines for children as young as six months, making it likely a nationwide rollout can start next week.

The 12-0 vote in favor of the move needs to be signed off by CDC Director Rochelle Walensky for the U.S. government to start rolling out the vaccines for children aged 5 and under.

The U.S. Food and Drug Administration (FDA) on Friday authorized Moderna's shot for children aged six months to 5 years, and Pfizer's vaccine for children aged six months to 4 years. Pfizer's vaccine is already authorized for children over the age of 5.

Please select this link to read the complete article from Reuters.

Printer-Friendly Version